linjc16/ctgov huggingface dataset:
ALN OATF Vena Cava Filter

Study Overview
=================
Brief Summary
-----------------
Migration of a thrombus in the pulmonary circulation is the leading cause of pulmonary embolism (PE). It can be prevented mechanically by implanting a vena cava filter (VCF) in the inferior vena cava. The implation of a VCF is indicated for patients with acute PE and a contraindication to anticoagulation, with an acute deep vein thrombosis (DVT) without PE and a contraindication to anticoagulation or with acute venous thromboembolism (less than 3 months) in whom an interventional gesture at hemorrhagic and thromboembolic risk contraindicates anticoagulation. The purpose of this study is to describe the rates of implantation, removal and complications associated with the use of the optional ALN OATF VCF in current practice.

Official Title
-----------------
Study of ALN's OATF Vena Cava Filter

Conditions
-----------------
Pulmonary Embolism

Intervention / Treatment
-----------------
* Device: Filter implantation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient implanted with an ALN OATF VCF Patient informed Exclusion Criteria: Minor patient Adult patient under a legal protection measure Pregnant, parturient or breastfeeding women Patient who refused to participate Patient who cannot or does not wish to be followed by the Interventional Radiology Department

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Vena Cava Filter<br>Participants implanted with the vena cava filter OATF (ALN) | Device: Filter implantation<br>* Implantation of OATF ALN vena cava filter<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Filter implantation | Rate of technical success of filter implantation | day 0 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Filter removal | Rate of filter removal | up to 1 year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Vena Cava Filter
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen

Study Overview
=================
Brief Summary
-----------------
The goal of this observational study aims to observe and evaluate the efficacy and safety of a liposomal doxorubicin containing regimen in the postoperative adjuvant treatment of breast cancer patients.

Official Title
-----------------
Clinical Observational Study of Postoperative Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen

Conditions
-----------------
Breast Cancer, Liposomal Doxorubicin, Efficacy, Safety, Postoperative Adjuvant Treatment

Intervention / Treatment
-----------------
* Drug: Liposomal doxorubicin containing regimen


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Female, aged 18-75 years; Primary breast cancer diagnosed histopathologically; Adjuvant chemotherapy regimens include liposomal doxorubicin; ECoG PS score: 0-1 points; Left ventricular ejection fraction (LVEF) ≥ 55%; Estimated survival ≥ 6 months; Major organ function is normal, i.e. meets the following criteria: ① And white blood cells ≥ 4.0 × 10 9 / L, neutrophil count (ANC) ≥ 1.5 × 10 9 /L；② Platelets ≥ 100 × 10 9 /L；③ And hemoglobin ≥ 10 g / dl; ④ Serum creatinine ≤ 1.5 × ⑤ the upper limit of normal (ULN) Mmol / L and aspartate transaminase (AST) ≤ 2.5 × ULN；⑥ Alanine transaminase (ALT) ≤ 2.5 × ULN；⑦ Total bilirubin ≤ 1.5 × ULN；⑧ Serum creatinine ≤ 1.5 × ULN； Subjects voluntarily join this study, sign the informed consent form, have good compliance and cooperate with follow-up. Exclusion Criteria: Pregnant, lactating patients; Breast cancer has been found to have distant metastasis; Those with peripheral nervous system disorders caused by the disease or with a history of significant mental disorders and central nervous system disorders; Those with severe infection or active peptic ulcer requiring treatment; Allergic to chemotherapy drugs; Cancer free period less than 5 years except for cured basal cell carcinoma of the skin and cured carcinoma in situ of the cervix; Severe liver disease (e.g., cirrhosis, etc.), renal disease, respiratory disease, or uncontrolled diabetes; Patients who are participating in other clinical trials or within a month.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Drug: Liposomal doxorubicin containing regimen|Liposomal doxorubicin hydrochloride (PLD) 30-40mg/m2 D1 + other drugs (decided by investigators); All patients were treated with 4 cycles.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Cardiac safety | Cardiac ejection fraction | 10 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Overall survival |  | 10 years |
The Risk of Falls Index for Patients With Neuromuscular Disorders

Study Overview
=================
Brief Summary
-----------------
The combination of short quantitatively assessing muscular function and balance in combination with short clinical scores, can be a new valid approach to evaluate the patient risk of fall and help to create a quick checkup test to prescribe an appropriate assistive device. The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with neuromuscular diseases (NMD) based on correlation between clinical assessments between two groups of NMD patients and scales used to assess risk of falling for patients.

Official Title
-----------------
The FBIndex to Determine the Risk of Falls and Its Translation to Assistive Gait Device Care for Patients With Neuromuscular Disorders

Conditions
-----------------
Inclusion Body Myositis, Myotonic Dystrophy, Facioscapulohumeral Muscular Dystrophies, Myasthenia Gravis, The Falls Efficacy Scale International, The Morse Fall Scale

Intervention / Treatment
-----------------
* Diagnostic Test: The risk of falls


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients between 18- and 65-year-old Patients with adequate cognitive and communication function to fill out the scales assessing risk of falling The neuromuscular disease needs to be confirmed by genetic report and/or disease deepening neurophysiological examination. Exclusion Criteria: - Patients which are not able to perform motoric functional assessments without assistive gait device.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Neuromuscular disorders<br> | Diagnostic Test: The risk of falls<br>* Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed. Test battery two includes Timed Up and Go test, 10 Meter Walk Test, Six Minute Walk test, The Falls Efficacy Scale International FES-I, The Morse Fall Scale.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| FBIndex | The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with NMDs based on correlation between clinical assessments: Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed, Timed Up and Go test, 10 Meter Walk Test and Six Minute Walk test, between two groups of NMD patients and scales: The Falls Efficacy Scale International FES-I and The Morse Fall Scale used to assess risk of falling for patients. | 2 years |
Different Algorithm Models to Predict Postoperative Pulmonary Complications in Elderly Patients

Study Overview
=================
Brief Summary
-----------------
Although a number of clinical predictive models were developed to predict postoperative pulmonary complications, few predictive models have been used in elderly patients. In this study, the researchers aim to compare different algorithms to predict postoperative pulmonary complications in elderly patients and to assess the risk of postoperative pulmonary complications in elderly patients.

Detailed Description
-----------------
Postoperative pulmonary complications occur frequently, which is an important cause of death and morbidity. Age has been an important predictor of postoperative pulmonary complications. As the world's population ages, more and more older people are undergoing surgery as indications for surgery expand. In order to better assess the risk of postoperative pulmonary complications in elderly patients, we plan to use database information and different algorithms such as logistic regression, random forest, and other algorithms to build models respectively and evaluate the effects of the models.

Official Title
-----------------
Different Algorithm Models to Predict Postoperative Pulmonary Complications in Elderly Patients

Conditions
-----------------
Postoperative Pulmonary Complications

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age 65 years or older receiving invasive ventilation during general anesthesia for surgery Exclusion Criteria: preoperative mechanical ventilation procedures related to a previous surgical complication a second operation after surgery organ transplantation discharged within 24 hours after surgery cardiac surgery

Ages Eligible for Study
-----------------
Minimum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Training set<br>The whole cohort is randomly assigned to a training cohort and validation cohort. | |
| validation set<br>The whole cohort is randomly assigned to a training cohort and validation cohort. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Postoperative pulmonary complications |  | within one week after surgery | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Postoperative pulmonary complications |  | 30 days after surgery |
Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being

Study Overview
=================
Brief Summary
-----------------
The main objective of this study is to carry out the psychometric validation of the PERMA-Profiler in a population representative of the general French population and in comparison with the reference questionnaire The PERMA-Profiler.

Official Title
-----------------
Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being

Conditions
-----------------
Psychiatric Disorder

Intervention / Treatment
-----------------
* Other: COHORT


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult (≥18 years). Person able to read and understand French Person willing to participate in this study Exclusion Criteria: The person does not understand the French language Person has a history of traumatic brain injury The person refuses to participate in the study

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: COHORT|this evaluation includes a brief interview with perma profiler scale|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| PERMA PROFILER French Version: diagnostic properties | sensitivity, specificity | DAY 0 |
Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

Study Overview
=================
Brief Summary
-----------------
This is a study assessing the interest of post-operative follow-up of asymptomatic papillary microcarcinomas. Today, this post-operative follow-up represents an economic cost and is a source of anxiety for patients. The aim of this study is to determine the global survival of patients with asymptomatic papillary microcarcinoma to assess the interest of a post-operative ultrasound and/or biological follow-up.

Official Title
-----------------
Interest of Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

Conditions
-----------------
Papillary Carcinoma

Intervention / Treatment
-----------------
* Other: Questionnaire


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with uni or multifocal papillary microcarcinoma (cumulative size of foci <10mm) asymptomatic or not and who underwent partial or total thyroidectomy from 2012 to 2017. Non opposition patient Affiliation to a social security scheme Exclusion Criteria: Lesion crossing the thyroid capsule, or cervical lymph node involvement clinical or histological cervical lymph node involvement. Patient under guardianship, curators or safeguard of justice

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Adult patients with a papillary microcarcinoma asymptomatic<br>Adult patients who have had a papillary microcarcinoma asymptomatic and who are followed. | Other: Questionnaire<br>* The questionnaire is about hypocalcemia, dysphonia and anxiety. It will be carried out by phone call for 10 minutes<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Overall survival | Review of medical record | 10 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Disease control rate | No recurrence clinically detected or by additional examen | 10 years | 
| Surgical complications rate | Dysphonia and hypocalcemia | 10 years | 
| Detection of recurrence rate | Recurrence detection by additional examen | 10 years | 
| Recovery surgical or iratherapie recovery rate | Anatomopathologic analysis | 10 years | 
| Anxiety evaluation | Likert scale | 1 month | 
| Prognostics survival criteria | Age during surgical | 1 month | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Papillary Carcinoma, Postoperative, Follow-up
Effectiveness of KT VS ST Along With Routine Physical Therapy Among Patients of Chronic Low Back Pain RCT

Study Overview
=================
Brief Summary
-----------------
To determine the effectiveness of Kineso taping (KT) Versus Sham taping along with routine physical therapy among Chronic Low Back pain (CLBP) patients.

Official Title
-----------------
Effectiveness of Kinesio Taping Versus Sham Taping Along With Routine Physical Therapy Among Patients of Chronic Low Back Pain A Randomised Trial

Conditions
-----------------
Low Back Pain

Intervention / Treatment
-----------------
* Diagnostic Test: Kinesio taping
* Diagnostic Test: Sham taping


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Pain in the area between 12 ribs and hip crease with or without leg pain. Age ranges from 18 to 65 years. Low back pain for 6 weeks. Moderate pain intensity with pain score. Exclusion Criteria: Known or suspected Spinal lesions. Spinal surgery within first 6 months. Physical Therapy for low back pain for past 6 months. Severe Complications.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Kinesio taping<br>Kinesotaping will be applied with routine physical therapy | Diagnostic Test: Kinesio taping<br>* Kinesotaping will be applied with routine physical therapy<br>|
| Experimental: Sham taping<br>Sham taping will be applied with routine physical therapy | Diagnostic Test: Sham taping<br>* Sham taping will be applied with routine physical therapy<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Oswestry Disability Index |  | 6 Months |
PBMT Influence on Alveolar Socket Preservation

Study Overview
=================
Brief Summary
-----------------
Goal of this study is to compare between the effect of two different low power lasers on extraction socket healing.

Detailed Description
-----------------
After molar tooth extraction, 6 Low power (PBMT) laser sessions. Evaluation: Visual Radiographic Histological

Official Title
-----------------
Influence of Photobiomodulation Therapy (PBMT) as an Adjunctive Therapy in Alveolar Socket Preservation Preceding Dental Implant Placement

Conditions
-----------------
Extraction Socket Healing

Intervention / Treatment
-----------------
* Procedure: Low power laser


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Fit for implant rehabilitation. Acceptable oral hygiene. Willingness to attend 6 visits within 15 days of extraction. Exclusion Criteria: Uncontrolled diabetes. Sub optimal oral hygiene. Heavy smoker.

Ages Eligible for Study
-----------------
Minimum Age: 30 Years
Maximum Age: 50 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Comparing between 2 laser' effect on extraction socket healing
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Red Laser<br>Photobiomodulation using nm Diode. | Procedure: Low power laser<br>* Phototherapy for extraction sockets using two different lasers.<br>|
| Active Comparator: Infrared Laser<br>Photobiomodulation using nm Diode. | Procedure: Low power laser<br>* Phototherapy for extraction sockets using two different lasers.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Radiographic socket dimensions | Alveolar Socket surface area measured on Cone Beam Computerised Tomography | 3 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Soft tissue healing | Landry, Turnbull, Howley healing index; scoring from 1 to 5 where 1 represents very poor healing while 5 denotes perfect healing. | 15 days | 
| Histological examination | Histological examination of bone samples | 3 months |
Lateral Epicondylitis Continuous Radiofrequency Microtenotomy

Study Overview
=================
Brief Summary
-----------------
prospective study measuring the outcome of continuous radio frequency 60 degree on lateral epicondylitis not responding to traditional ultrasound guided injection

Official Title
-----------------
Efficacy of Continuous Radiofrequency 60 Celsius Degree in Management of Chronic Lateral Epicondylitis Prospective Study

Conditions
-----------------
Tennis Elbow

Intervention / Treatment
-----------------
* Procedure: 60 degree thermal radiofequency of tennis elbow


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: chronic tennis elbow no response to traditional injection ultrasound exam reveal swelling of common extensor tendon Exclusion Criteria: complete tear of common extensor tendon implanted pace maker

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: lateral epicondylitis<br>chronic patients of tennis elbow | Procedure: 60 degree thermal radiofequency of tennis elbow<br>* under strict aseptic technique ultrasound guided TRF of lateral epicondylitis advanced for 5 mm active tip canula<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| decrease in pain score after CRF | decrease in numerical analogue score | 6 months |